GlassScriptPhysician profile
Joseph C Hegarty
NPI 1811942535
$12,359.39
in general payments reported to CMS, 2019-2025
31 companies · $1,828 in 2025
The $1,828 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $819 · 2021: $1,541 · 2022: $2,260 · 2023: $3,251 · 2024: $1,531 · 2025: $1,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,987 · Travel and Lodging: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,987.32 |
| Travel and Lodging | $622.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,317.69 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Relievant Medsystems, INC. | $902.57 | 2023 | Intracept |
| Collegium Pharmaceutical, INC. | $589.86 | 2021-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $478.93 | 2019-2025 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $354.71 | 2019-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $257.91 | 2022-2025 | Relistor |
| Forte Bio-Pharma LLC | $217.27 | 2020-2024 | Prolate, Nalocet |
| Abbvie INC. | $184.92 | 2021-2025 | |
| Sentynl Therapeutics, INC. | $177.82 | 2019-2020 | |
| Globus Medical, INC. | $161.67 | 2025 | Senza |
| Biodelivery Sciences International, INC. | $103.72 | 2019-2021 | |
| Pfizer INC. | $92.43 | 2019-2021 | |
| Saluda Medical Americas, INC. | $55.31 | 2025 | Evoke |
| Allergan, INC. | $53.89 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $45.24 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.64 | 2021-2025 | Evenity, Prolia |
| Stryker Corporation | $32.67 | 2025 | Mild Device Kit |
| Virtus Pharmaceuticals LLC | $31.54 | 2021-2025 | Levorphanol Tartrate |
| Nevro Corp. | $31.42 | 2023-2024 | Senza |
| Avanos Medical | $28.35 | 2024 | Coolief* Cooled Radiofrequency |
| Pacira Therapeutics, INC. | $24.25 | 2019 | |
| Biotronik Nro, INC. | $23.40 | 2025 | Prospera |
| Grt US Holding, INC. | $21.95 | 2021 | |
| Ibsa Pharma INC. | $18.52 | 2021 | |
| Protega Pharmaceutials INC | $18.48 | 2023 | Roxybond |
| Medtronic, INC. | $18.18 | 2022 | |
| Shionogi INC | $18.13 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.96 | 2019 | |
| Redhill Biopharma INC. | $16.64 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.45 | 2023 | Iovera, Zilretta |
| Tonix Medicines, INC. | $13.87 | 2025 | Tonmya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Hegarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.